Tribune Therapeutics

Investment area
Novo Seeds
Date of investment
June 2021

Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.

Tribune Therapeutics

Investment area
Novo Seeds
Date of investment
June 2021

Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.

Tribune Therapeutics

Investment area
Novo Seeds
Date of investment
June 2021

Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.